Consequences of COVID-19 on people with diabetes

Bellido, Virginia; Pérez, Antonio

doi:10.1016/j.endien.2020.04.008

Cited by 11 publications

(9 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[22][23][24] However, the Covid pandemic could have reduced the capacity of routinely managing diabetes, and access to pharmacologic treatments, or increased stress associated with confinement. 25 In 2018, a longer duration of diabetes and taking pharmacologic treatment was associated with lower control levels, in line with Ensanut's 2016 findings. 3 However, the association with pharmacologic treatment could be a result of reverse causality, as pharmacologic treatment is an indicator of severity and is recommended to individuals with uncontrolled glycemia.…”

Section: Discussionsupporting

confidence: 57%

Prevalence of diabetes and glycemic control in Mexico: national results from 2018 and 2020

et al. 2021

View full text Add to dashboard Cite

Objective. To estimate the prevalence of diabetes (diagnosed and undiagnosed), glycemic control in Mexico, and its associated factors. Materials and methods. We used data from Ensanut 2018 (n=12 648) and 2020 (n=2 309). We defined diabetes as fasting glucose ≥126 mg/dl or HbA1c≥6.5% or previously diagnosed; glycemic control was defined as HbA1c<7%. We fitted Poisson regression models to assess the association between diabetes, glycemic control, and potential associated factors. Results. The total prevalence of diabetes was 16.8% in 2018 and 15.7% in 2020. In 2018, 38% of adults with diabetes were unaware of their disease, while in 2020 this figure was 29%. Glycemic control was observed in 42% of participants in 2018 and 39% in 2020. Longer disease duration was associated with lower glycemic control, while older age, having a diet, and being affiliated to IMSS, Pemex, Sedena, or private healthcare were associated with better control. Conclusion. Mexico is among the countries with the highest diabetes prevalence. A high proportion of adults with diabetes did not have a previous diagnosis, and the proportion with glycemic control is low. Strengthening screening to achieve a timely diagnosis, and improving glycemic control, should be key actions in the management of diabetes.

show abstract

Section: Discussionsupporting

confidence: 57%

Prevalence of diabetes and glycemic control in Mexico: national results from 2018 and 2020

et al. 2021

View full text Add to dashboard Cite

show abstract

“…A study of the Great East Japan Earthquake of 2011 showed a 5% increase in the prevalence of GDM among the most affected residents compared to those who were not affected ( 24 ). On top of that, during the COVID-19 lockdown, an Indian cohort study found an increased risk of type 2 diabetes ( 25 ), and some other studies found that lockdown measures designed to avoid SARS-CoV-2 transmission may contribute to the deterioration of control in patients with diabetes ( 9 , 10 ).…”

Section: Discussionmentioning

confidence: 99%

“…For example, many cities and regions have fully or partially implemented lockdown measures, with large venues closed and traffic restricted. Apart from the control of pandemic, these measures during the lockdown have not only led to economic recessions, but also the strain on medical resources ( 6 – 8 ), which has substantially affected health in the public such as glycemic control in diabetic patients ( 9 , 10 ).…”

Section: Introductionmentioning

confidence: 99%

Association of COVID-19 Lockdown With Gestational Diabetes Mellitus

Zheng

et al. 2022

Front. Endocrinol.

View full text Add to dashboard Cite

ImportanceThe ongoing pandemic of COVID-19 is still affecting our life, but the effects of lockdown measures on gestational diabetes mellitus (GDM) in pregnant women remain unclear.AimTo investigate the association between COVID-19 lockdown and GDM.Subjects and MethodsMedical records of 140844 pregnant women during 2015-2020 were extracted from 5 hospitals in Guangdong Province, China. Pregnant women who underwent the COVID-19 Level I lockdown (1/23 - 2/24/2020) during pregnancy were defined as the exposed group (N=20472) and pregnant women who underwent the same calendar months during 2015-2019 (1/23 - 2/24) were defined as the unexposed group (N=120372). Subgroup analyses were used to explore the potential susceptible exposure window of COVID-19 lockdown on GDM. Cumulative exposure is quantitatively estimated by assigning different weights to response periods with different exposure intensities. A logistic regression model was used to estimate the association between COVID-19 lockdown exposure and GDM.ResultsThe rates of GDM in the exposed and unexposed groups were 15.2% and 12.4%, respectively. The overall analyses showed positive associations (odds ratio, OR=1.22, 95%CI: 1.17, 1.27) between lockdown exposure and GDM risk in all pregnant women. More pronounced associations were found in women who underwent the COVID-19 lockdown in their first four months of pregnancy, and the adjusted OR values ranged from 1.24 (95%CI: 1.10, 1.39) in women with 5-8 gestational weeks (GWs) to 1.35 (95%CI: 1.20, 1.52) with < 5 GWs. In addition, we found a positive exposure-response association of cumulative lockdown exposure with the risk of GDM.ConclusionsThe COVID-19 lockdown was associated with an increased risk of GDM, and the first four months of pregnancy may be the window for sensitive exposure.

show abstract

“…Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022:15 3410 activity and increased stress or anxiety associated with lockdown. [15][16][17] Anxiety in people with T1D has been associated with less frequent BG monitoring and suboptimal glycemic control. 18 Non-compliance with the diet, to a greater extent, than the stress and anxiety caused by the pandemic (to a lesser extent), led to the occurrence of hyperglycemic episodes.…”

Section: Dovepressmentioning

confidence: 99%

The Impact of COVID-19 Lockdown on Glycemic Balance in Romanian Patients with Type 1 Diabetes Mellitus

Gherbon¹,

Frandeș²,

Timar³

et al. 2022

DMSO

View full text Add to dashboard Cite

Introduction The COVID-19 pandemic has brought major changes not only at the economic and social level but especially in the medical system. Objective To evaluate the impact of COVID-19 lockdown on the quality of glycemic control in Romanian patients with type 1 diabetes mellitus (T1DM). Material and Method Our study group included 102 Romanian volunteers’ patients with T1DM from both urban and rural areas. Data were collected during an interview, based on a structured questionnaire with multiple-choice questions about diabetes management during lockdown, how they interact with their diabetologist, how they accessed the treatment and what other factors influenced their diabetes management during the lockdown. Results Blood glucose levels were significantly higher in the MDII group as a consequence of delayed administration of insulin corrections due to inadequate insulin dosing (60% vs 31.81%; χ 2 = 5.51, p = 0.018). In addition, insulin pump users had improved response to stress and anxiety (ie, additional therapeutic safety being provided by use of insulin pump; in some devices, blood glucose being continuously monitored, leading to premature detection of important blood glucose excursions) compared to insulin pen users ( χ 2 = 5.09, p = 0.024). In the context of hypoglycemia, we observed that in the pen MDII group, more users have administered an excess of insulin, compared with the pump users (80% vs 45.45%; χ 2 = 10.34; p = 0.001). Conclusion A lower impact of COVID-19 lockdown on glycemic control was observed in patients with T1DM treated using insulin pumps compared to patients with T1DM who administered their insulin using insulin pens. Telemedicine and online consultations have brought significant improvements in diseases management. Stress, emotions, and anxiety were among the main reasons that led to increases in blood sugar levels, suggesting that the psychological impact may have long-term complications.

show abstract

Consequences of COVID-19 on people with diabetes

Cited by 11 publications

References 15 publications

Prevalence of diabetes and glycemic control in Mexico: national results from 2018 and 2020

Prevalence of diabetes and glycemic control in Mexico: national results from 2018 and 2020

Association of COVID-19 Lockdown With Gestational Diabetes Mellitus

The Impact of COVID-19 Lockdown on Glycemic Balance in Romanian Patients with Type 1 Diabetes Mellitus

Contact Info

Product

Resources

About